Despite the relatively mild reported sequelae of CCH due to TRHR mutations, T4 replacement ameliorates growth retardation and improves quality of life; additionally, detailed neuropsychological assessment (not undertaken in published cases) could plausibly delineate subtle neurological benefits (2, 3). The gene discussed is TRHR; the disease is columnar cell hyperplasia of the breast.